🔎 Trials Near Me

Akèy › Pirura Trombositopenik Idyopatik › Kalifòni

Etid klinik pou Pirura Trombositopenik Idyopatik nan Kalifòni

10 etid pou Pirura Trombositopenik Idyopatik ap chèche patisipan nan sit nan Kalifòni.

Vil nan Kalifòni

Tèks ofisyèl etid la (Anglè)

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center, Los Angeles
  • Stanford University, Palo Alto
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06721013

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
  • University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06722235

A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)

  • MemorialCare Long Beach Medical Center, Long Beach
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Sep 17, 2026 · NCT07700238

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

  • Usc Norris Comprehensive Cancer Center, Los Angeles
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07104565

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

  • University of Southern California, Los Angeles
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 11, 2026 · NCT07059000

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
  • University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06948318

OM336 in Autoimmune Cytopenias

  • City of Hope, Duarte
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Sep 3, 2026 · NCT07083960

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

  • University of California-Irvine, Orange
Ap rekriteFaz 1
Laj 18 a 85 · Tout sèks · Mizajou Jul 22, 2026 · NCT06371417

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

  • Community Health Partners (CHP) - Community Medical Oncology Specialists (University Oncology Associates), Clovis
  • University of Southern California (USC), Los Angeles
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jun 22, 2026 · NCT07007962

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

  • University of Southern California Norris Comprehensive Cancer Center, Los Angeles
  • Sharp Memorial Hospital, Oceanside
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 1, 2026 · NCT06544499

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.